Biological Evaluation of 5′-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors-Reference-Cited by-同舟云学术

Biological Evaluation of 5′-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors

Published:2021-03-01 Issue:3 Volume:12 Page:373-379
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Tosh Dilip K.¹,Brackett Christopher M.²,Jung Young-Hwan¹,Gao Zhan-Guo¹,Banerjee Monimoy²,Blagg Brian S. J.²^ORCID,Jacobson Kenneth A.¹^ORCID

Affiliation:

1. Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States

2. Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States

Funder

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00509

Reference32 articles.

1. Structure, Function and Regulation of the Hsp90 Machinery

2. Hallmarks of Cancer: The Next Generation

3. The Therapeutic Target Hsp90 and Cancer Hallmarks

4. Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

5. Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects;Journal of Medicinal Chemistry;2024-09-10

2. N‐Glycosylation‐Induced Pathologic Protein Conformations as a Tool to Guide the Selection of Biologically Active Small Molecules;Chemistry – A European Journal;2024-09-09

3. How aberrant N-glycosylation can alter protein functionality and ligand binding: An atomistic view;Structure;2023-08

4. Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities;Pharmacology & Therapeutics;2023-05

5. Scaffold Hopping and Screening for Potent Small Molecule Agonists for GRP94: Implications to Alleviate ER Stress-Associated Pathogenesis;Molecular Biotechnology;2023-02-10